2025 Simposio de la AF: Actualización del canal de desarrollo de medicamentos de AF (7)
Автор: Friedreich's Ataxia Research Alliance
Загружено: 2025-10-30
Просмотров: 19
Описание:
Actualización del canal de desarrollo de medicamentos de AF y panel de preguntas y respuestas
Moderado por Jennifer Farmer, directora ejecutiva de FARA
Representantes de Biogen, Design Therapeutics, Larimar Therapeutics, Lexeo Therapeutics, PTC Therapeutics y Solid Biosciences
Los servicios de interpretación en español son posibles gracias al apoyo de Biogen.
Proporcionado por Equal Access Language Services, LLC.
FARA's Mission is to marshal and focus the resources and relationships needed to cure Friedreich's Ataxia (FA) by raising funds for research, promoting public awareness, and aligning scientists, patients, clinicians, government agencies, pharmaceutical companies and other organizations dedicated to curing FA and related diseases.
Friedreich’s Ataxia is a debilitating, life-shortening, degenerative neuro-muscular disorder. About one in 50,000 people in the United States have Friedreich's Ataxia.
Subscribe to FARA's YouTube channel / fara1998
Follow FARA on Facebook / curefa
Follow FARA on Instagram / curefa_org
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
